You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Pulmonary involvement in Fabry disease: effect of plasma globotriaosylsphingosine and time to initiation of enzyme replacement therapy

Article metrics

Article menu

Download PDFPDF

Orphan lung disease
Pulmonary involvement in Fabry disease: effect of plasma globotriaosylsphingosine and time to initiation of enzyme replacement therapy

 

Online download statistics by month:

Online download statistics by month: April 2018 to March 2024

AbstractFullPdf
Apr 20189610215
May 201819720858
Jun 2018565620
Jul 2018606021
Aug 201834337
Sep 2018676713
Oct 201814512719
Nov 201818218219
Dec 201816316323
Jan 20191441428
Feb 201913913811
Mar 2019818024
Apr 201931288
May 2019353413
Jun 201927259
Jul 2019292814
Aug 201930298
Sep 201919195
Oct 201945448
Nov 201928277
Dec 201924246
Jan 202018184
Feb 2020414011
Mar 2020313111
Apr 202010109
May 202027267
Jun 202028277
Jul 202045444
Aug 202019208
Sep 2020413611
Oct 202024243
Nov 2020232312
Dec 202021193
Jan 202127269
Feb 2021222011
Mar 202121206
Apr 202126238
May 2021272411
Jun 202122207
Jul 202114146
Aug 202117155
Sep 202119198
Oct 2021353420
Nov 2021212117
Dec 202127265
Jan 202226258
Feb 202217182
Mar 202225258
Apr 202235357
May 2022545215
Jun 2022454510
Jul 202234343
Aug 202236366
Sep 2022404013
Oct 202245459
Nov 2022353626
Dec 2022252410
Jan 2023282813
Feb 202336365
Mar 202326278
Apr 202323255
May 2023282910
Jun 202335355
Jul 2023505025
Aug 202327288
Sep 202319195
Oct 202332337
Nov 202332335
Dec 202325257
Jan 202413144
Feb 202413145
Mar 2024293010
Total30713037758